中华保险始终以"服务国家、服务三农、服务民生，为人民群众提供保险保障"为使命，紧扣国家部署， 将主责主业融入乡村振兴、健康中国、绿色发展等重大战略，用保险力量筑牢民生底线，构建起多层 次、广覆盖的金融服务体系，激活产业动能，切实服务大局，将国家战略所指、实体经济所需、民生福 祉所系作为创新的出发点与落脚点，充分展现了国有企业的责任与担当。同时，该公司积极深化改革创 新，强化风险管理，加速推进数字化转型，持续提升客户体验与服务效能，为业绩持续增长不断注入新 动能。 面向未来，中华保险将坚定不移贯彻落实国家关于金融工作的决策部署，在中投公司及东方公司的战略 引领下，有力践行"金融为民"理念，切实发挥保险经济减震器和社会稳定器功能，在服务现代化产业体 系建设、促进共同富裕、保障国家粮食与能源安全等领域展现新担当、实现新作为，为中国式现代化建 设贡献更为坚实的保险力量。 原标题：深耕笃行 稳健攀升 中华保险连续十年登榜"中国企业500强" 9月15日，中国企业联合会、中国企业家协会在北京发布"2025中国企业500强"榜单。中华保险凭借稳健 的经营业绩和卓越的综合实力连续第十年登榜，在"2025中国企业500强"榜单 ...

9月14日，"草木皆兵"全民篮球积分挑战赛启动仪式暨揭幕战在北京国家奥体中心成功举办。这场面向 大众的原创篮球赛事，以"草木皆兵"为主题，寓意着每一位篮球爱好者都能投身其中，共享这场全民篮 球的狂欢盛宴。 运动，无疑是保持身体健康的天然良方。联盛医药集团始终秉持"让生命更加健康瑞禧"的企业使命，积 极响应"健康中国"战略号召，深度参与本次"草木皆兵"全民篮球赛事，并与主办方我奥体育达成战略合 作，全力支持该赛事在全国范围内的推广，以实际行动为全民健康事业添砖加瓦。 此外，联盛医药集团联合我奥体育特别策划了集趣味与挑战于一体的快乐篮球罚篮"联"胜赛。罚篮连中 挑战环节成为全场焦点，吸引了多位篮球界知名人士与爱好者踊跃参与，包括篮球名宿宋晓波、篮球网 红"超级草根"魏师傅、CUBA历史三分王张佳滨等。最终，张佳滨凭借连续命中30记罚球的出色表现， 夺得该环节冠军。 作为一家专注于经皮给药的医药企业，联盛医药集团不仅在篮球赛事推广上积极作为，更以科技力量 为"健康中国"战略保驾护航。鉴于篮球运动对抗激烈，常见肌肉拉伤、关节扭伤等情况，集团公益赞助 三千余盒联盛贴片，为所有参赛选手提供肌骨健康保障，助力运动员安心竞技 ...

Group 1 - The 25th China International Investment and Trade Fair (CIFIT) was held in Xiamen, focusing on global investment opportunities and cooperation development [1] - Pizhou Pharmaceutical, as a leading enterprise in the traditional Chinese medicine health industry in Zhangzhou, showcased its industry advantages and development vitality at the fair [1][3] - The theme of the fair was "Join Hands with China, Invest in the Future," highlighting investment hotspots and opportunities [1] Group 2 - Pizhou Pharmaceutical presented a diverse range of high-quality health products, including traditional medicines and health foods, emphasizing its product matrix [3] - The company highlighted its core business in traditional Chinese medicine while expanding into biomedicine, cosmetics, and health food sectors [5] - Pizhou Pharmaceutical is actively implementing the "Healthy China" strategy and aligning with local government initiatives to promote the integration of traditional Chinese medicine [5]

Core Insights - The establishment of the National Artificial Intelligence Application Pilot Base in the medical field is a significant step in promoting AI applications in healthcare, aiming to enhance service efficiency and patient outcomes [1][5][6] - The base serves as a comprehensive "incubation factory" for hospitals and enterprises, providing a full range of services from diagnosis to drug development [1][5] - The AI interactive experience area at the base has attracted significant public interest, showcasing products like the "Fundus Disease and Major Chronic Disease Early Warning System," which can quickly identify various health risks [2][3] Group 1: AI Application and Services - The pilot base has launched 31 AI medical interactive products, with a focus on early detection of diseases through advanced imaging technology [1][2] - The "Fundus Disease and Major Chronic Disease Early Warning System" can automatically generate analysis reports within three minutes, identifying over 30 eye diseases and 10 systemic risks [2] - The base aims to create a unified support platform for medical institutions and technology companies, facilitating the entire process from technology validation to clinical trials and product promotion [5][6] Group 2: Challenges and Solutions - Data challenges, including ownership ambiguity and compliance issues, are significant hurdles in the development of AI applications in healthcare [7] - The base is working on establishing a trusted data space to facilitate the secure and efficient use of medical data, addressing the need for a robust data infrastructure [7][8] - A medical big model and application evaluation system is being developed to provide standardized assessments of AI applications in real clinical settings, ensuring quality and compliance [8] Group 3: Future Outlook - The pilot base envisions a future where efficient collaboration among enterprises and hospitals eliminates barriers to data access and product commercialization [9] - By leveraging AI for proactive health monitoring, the base aims to reduce disease incidence and enhance public health outcomes [9] - The ultimate goal is to integrate AI deeply into healthcare, allowing for early risk identification and timely interventions, thereby improving overall health value for individuals [9]

Core Viewpoint - The strategic cooperation between Mengniu Group and Huati Group aims to integrate the sports industry with the dairy industry, enhancing the development of both sectors and contributing to the "Healthy China" and "Sports Power" strategies [3][6]. Group 1: Strategic Cooperation - Mengniu Group and Huati Group have reached a strategic partnership to leverage their respective strengths for the deep integration of the sports and dairy industries [3]. - The collaboration will focus on resource integration, product fusion, scenario co-creation, and brand building to innovate sports service models and upgrade the industry [3][4]. Group 2: Marketing and Product Innovation - The partnership will break traditional marketing models by incorporating nutritional services into various sports scenarios, promoting the core marketing concept of "Strong Body through Sports, Nutrition as Support" [3][4]. - Both companies will engage in joint research and development to upgrade dairy products from basic nutrition to precise and functional nutrition, fostering a healthy consumption market [4]. Group 3: Public Engagement and Health Promotion - The collaboration aims to enhance public participation in healthy sports through diversified scenarios, including event operations, venue services, hotel cooperation, sports training, and national fitness initiatives [4]. - Mengniu Group's commitment to national health and the sports industry is reinforced through this partnership, marking a significant step in supporting China's sports endeavors [3][6].

Core Points - The "Waterdrop Rural Medical Room: Hundred Counties and Thousand Villages Public Welfare Program" aims to enhance basic medical resources and emergency rescue knowledge in rural areas of China, particularly benefiting school children and villagers [1][3] - The program focuses on building standardized medical rooms, equipping them with basic medical devices, and providing emergency response training to improve public health services in rural regions [3][4] - By August 2025, the program plans to establish 1,000 medical rooms across 100 counties, contributing to the "Rural Revitalization" and "Healthy China" strategies [8] Summary by Sections - **Program Overview** - The initiative addresses the lack of emergency medical resources in rural areas, aiming to improve health safety for villagers and school children [1][3] - **Implementation and Impact** - As of August 2025, 183 rural medical rooms have been established in 20 provinces, benefiting over 500,000 individuals [4] - **Recognition and Awards** - The program has received multiple accolades, including the Gold Award at the China Public Welfare Charity Project Competition in 2018 and the Second Prize at the Beijing Public Welfare Venture Competition in 2024, highlighting its effectiveness and sustainability [6] - **Future Goals** - The program sets a clear target to build 1,000 medical rooms by 2030, aiming to create a comprehensive health protection network in rural areas [8]

Core Insights - The "Artificial Intelligence + Healthcare" seminar held during the 2025 China International Service Trade Fair focused on the latest trends in the industry and announced multiple achievements from the National AI Application Pilot Base in the healthcare sector [2] - The State Council's recent document emphasizes the promotion of high-level health assistants accessible to all, aiming to enhance the efficiency and capability of grassroots healthcare services through AI applications [2] Group 1: AI in Healthcare - The pilot base aims to serve medical institutions, research institutes, and technology companies by creating a comprehensive service system that accelerates the incubation of AI achievements in healthcare, making services safer, more efficient, equitable, and accessible [3] - The base will also support pharmaceutical companies and research institutions by establishing a full-process service system for drug development, enhancing the efficiency of drug research and development [3] Group 2: Strategic Advantages - The Deputy Director of Beijing Municipal Health Commission highlighted the potential advantages in high-value scenarios, quality data, and high-level organization in the global AI technology competition [3] - The focus will be on increasing effective supply, addressing high mortality and disease burden diseases, promoting equitable access to quality medical resources, ensuring safety and quality, and controlling costs [3] Group 3: Data and Evaluation - A specialized assessment system has been developed, integrating multimodal data and authoritative medical knowledge, to enhance the clinical relevance and differentiation of AI models [4] - The assessment data set is derived from benchmark textbooks, latest disease guidelines, and real clinical data, allowing for comprehensive evaluation of AI models in various complex tasks [4] Group 4: Future Prospects - The seminar also announced the achievements of the pilot base and high-quality datasets for specialized diseases, promoting the implementation and industrialization of AI in healthcare [5] - The establishment of a secure and efficient medical data circulation scheme supports the safe transfer and value release of high-quality medical datasets [5] - The AI application promotion service aims to unify and integrate AI applications, currently covering over 100 applications across 30 key clinical scenarios, enhancing service delivery to doctors and patients [5]

Core Insights - The seminar on "Artificial Intelligence + Healthcare" was successfully held during the 2025 China International Service Trade Fair, focusing on the latest trends in the industry and the achievements of the national AI application pilot base in healthcare [2] - The State Council's recent document emphasizes the promotion of high-level health assistants and the application of AI in various healthcare scenarios to significantly enhance the capabilities and efficiency of grassroots medical services [2] Group 1: AI Application in Healthcare - The pilot base aims to serve medical institutions, research institutes, and technology companies by creating a comprehensive service system that accelerates the incubation of AI results in healthcare [3] - The base will also support pharmaceutical companies and research institutions by establishing a full-process service system for drug development, enhancing the efficiency of drug research and development [3] - The Beijing Health Commission highlighted the potential advantages in high-value scenarios, quality data, and high-level organization to address major health issues and improve resource accessibility [3] Group 2: Data and Evaluation Systems - A specialized evaluation system has been developed, integrating multimodal data and authoritative medical knowledge, to enhance the clinical relevance and differentiation of AI models [4] - The evaluation dataset is derived from benchmark textbooks, latest disease guidelines, and real clinical data, ensuring comprehensive assessment capabilities [4] Group 3: Future Prospects and Innovations - The seminar announced significant achievements of the pilot base, including the establishment of a secure and efficient medical data circulation scheme, supporting high-quality medical data flow and value release [5] - AI application promotion services have been developed, unifying management and operations of over a hundred AI applications across 30 critical clinical scenarios [5] - The acceleration of these innovations is expected to reshape healthcare service models and contribute to the "Healthy China" initiative [6]

面向精准诊疗，中试基地将服务医疗机构、科研院所和科技企业等行业主体，打造"需求验证-产品研 发-应用推广"全流程服务体系，加速医疗人工智能成果孵化，让医疗健康服务更加安全、高效、公平、 可及。面向生物医药制造，中试基地将携手生态合作伙伴构筑新一代研发基础设施，构建"药物发现— 临床前研究—临床试验—上市审批"全流程服务体系，助力药物研发智能化转型，实现全流程提速增 效，释放生物医药制造创新潜能。 北京商报讯(记者王寅浩实习记者宋雨盈)9月10日，在2025年中国国际服务贸易交易会上，北京市正式 启动医疗领域国家人工智能应用中试基地建设。为落实"健康中国"战略和"人工智能+"行动，促进人工 智能与医疗健康双向赋能，北京市积极响应国家战略，市卫生健康委联合市发展改革委积极申报，成功 获批首批国家人工智能应用中试基地。 据介绍，北京具备人工智能和生物医药产业领先优势，将充分发挥北京医疗行业应用场景广、数据体量 大、病种覆盖宽、服务纵深长、三医联动信息化基础好等特点，聚焦行业共性问题，构建行业共创平 台，构建算力协调供给、数据集成开放、模型组合演进、应用高效开发的全栈式共性支撑能力，培育产 业共赢生态，形成面向精准诊 ...

面向精准诊疗，中试基地将服务医疗机构、科研院所和科技企业等行业主体，打造"需求验证-产品研 发-应用推广"全流程服务体系，加速医疗人工智能成果孵化，让医疗健康服务更加安全、高效、公平、 可及。面向生物医药制造，中试基地将携手生态合作伙伴构筑新一代研发基础设施，构建"药物发现— 临床前研究—临床试验—上市审批"全流程服务体系，助力药物研发智能化转型，实现全流程提速增 效，释放生物医药制造创新潜能。 北京商报讯（记者 王寅浩 实习记者 宋雨盈）9月10日，在2025年中国国际服务贸易交易会上，北京市 正式启动医疗领域国家人工智能应用中试基地建设。为落实"健康中国"战略和"人工智能+"行动，促进 人工智能与医疗健康双向赋能，北京市积极响应国家战略，市卫生健康委联合市发展改革委积极申报， 成功获批首批国家人工智能应用中试基地。 据介绍，北京具备人工智能和生物医药产业领先优势，将充分发挥北京医疗行业应用场景广、数据体量 大、病种覆盖宽、服务纵深长、三医联动信息化基础好等特点，聚焦行业共性问题，构建行业共创平 台，构建算力协调供给、数据集成开放、模型组合演进、应用高效开发的全栈式共性支撑能力，培育产 业共赢生态，形成面向 ...